The comminution or desagglomeration of active pharmaceutical ingredients (API) is called micronization and brings about several advantages. The increase of the particle surface caused by the comminution results in a considerably better dissolution rate and bioavailability of the agents and therefore the APIs act faster. Due to the increased bioavailability a lower amount of APIs is required which in turn leads to a more cost-efficient product with less risks and side effects for the patient.
Based on comprehensive experience with the production of GMP-compliant pharmaceutical products, all sizes of NETZSCH DeltaVita® machines ranging from small laboratory- to production-size machines excel by the following specific features:
• All product wetted parts are designed and manufactured according to the latest GMP standards
• Material, production and calibration certificates are supplied together with the machine
• Optional cleaning in place (CIP) and sterilization in place (SIP)
• All indirectly product-wetted surfaces are made of stainless steel
• Optional data recording and formulation management
• Operator management with password protection for different levels of security
• Laboratory mills can be used with variable grinding chamber sizes
• Various materials like NETZSCH-Ceram Z, stainless steel 316 or nylon grinding chamber designs are available
• Splash-proof machine stand
• Comprehensive testing and qualification documentation, FAT, IQ, OQ, process validation
• Trainings and seminars